Trial Profile
Evaluation of therapeutic effect of compound Danshen dripping pills in the treatment of stable exertional angina pectoris.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs T 89 (Primary) ; Aspirin
- Indications Angina pectoris
- Focus Adverse reactions
- 24 Dec 2017 Planned number of patients changed from 120 to 60.
- 24 Dec 2017 Status changed from not yet recruiting to recruiting.
- 23 Sep 2017 Planned number of patients changed from 60 to 120.